Soleno Therapeutics, Inc. (SLNO): Price and Financial Metrics

Soleno Therapeutics, Inc. (SLNO): $37.79

0.73 (-1.90%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add SLNO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#289 of 362

in industry

SLNO Price/Volume Stats

Current price $37.79 52-week high $53.82
Prev. close $38.52 52-week low $3.00
Day low $37.40 Volume 306,600
Day high $38.80 Avg. volume 301,714
50-day MA $44.67 Dividend yield N/A
200-day MA $27.09 Market Cap 1.23B

SLNO Stock Price Chart Interactive Chart >


Soleno Therapeutics, Inc. (SLNO) Company Bio


Soleno Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, diazoxide choline controlled-release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is entering into Phase II/III clinical development. It also markets medical devices, including the CoSense End-Tidal Carbon Monoxide (ETCO) monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns; and NeoPip T-piece resuscitator and related consumables, which deliver consistent pre-set inspiratory pressure and positive end-expiratory pressures, as well as temperature probes, scales, surgical tables, and patient surfaces. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. May 2017. Soleno Therapeutics, Inc. was founded in 1999 and is based in Redwood City, California.


SLNO Latest News Stream


Event/Time News Detail
Loading, please wait...

SLNO Latest Social Stream


Loading social stream, please wait...

View Full SLNO Social Stream

Latest SLNO News From Around the Web

Below are the latest news stories about SOLENO THERAPEUTICS INC that investors may wish to consider to help them evaluate SLNO as an investment opportunity.

Why Soleno Therapeutics Stock Ticked Higher on Thursday

The latest pundit take on the stock provided a good reason for bulls to snap it up.

Yahoo | December 21, 2023

Growth Stocks Under $50 for December 2023

These are seven of the best-performing growth stocks for December 2023 based on above-average returns.

Yahoo | December 15, 2023

Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023

These three stocks to take profits on rallied more than 200% this year.

Ian Bezek on InvestorPlace | December 14, 2023

3 Stock Winners That Are Up 500% or More in 2023

If you want to find 2023's top-performing stock, check out these companies that returned 500% or more since January

Jeremy Flint on InvestorPlace | December 14, 2023

Insider Sell Alert: CEO Bhatnagar Anish Unloads 93,408 Shares of Soleno Therapeutics Inc (SLNO)

In a notable insider sell transaction, CEO Bhatnagar Anish of Soleno Therapeutics Inc (NASDAQ:SLNO) parted with 93,408 shares of the company on December 11, 2023.

Yahoo | December 14, 2023

Read More 'SLNO' Stories Here

SLNO Price Returns

1-mo -12.28%
3-mo -13.27%
6-mo 59.99%
1-year 967.51%
3-year 119.07%
5-year 24.72%
YTD -6.11%
2023 1,932.83%
2022 -67.80%
2021 -78.76%
2020 -34.35%
2019 71.93%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!